tradingkey.logo
tradingkey.logo
Search

Ionis Pharmaceuticals Inc

IONS
Add to Watchlist
62.040USD
+2.300+3.85%
Close 08-21 16:00ET
10.28BMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+3.85%

5 Days

+8.39%

1 Month

+11.04%

6 Months

-26.67%

Year to Date

-21.58%

1 Year

+45.33%

Key Figures
60.535Open
62.060High
204.61KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.12%Turnover Ratio
59.740Prev. Close
59.760Low
12.53MTurnover
LossP/E Static
23.38P/B
0.00%Div Yield TTM
-10.44%ROA
86.74052wk High
0.08Volume Ratio
-453.90MNet Profit
165.64MShares
-2.0190EPS TTM
0.38Beta
-67.62%ROE
41.71052wk Low
3.85%Amplitude
98.98%Gross Margin
10.28BMarket Cap
3.69Reward/Risk
3.35%Risk Rate

Ionis Pharmaceuticals Inc's Score

0.05vs previous score
Forecast8.00
Financial Health6.96
Technical4.01
Valuation Dimensions8.62
Institutional Confidence10.00
Risk Assessment5.86

Media Coverage

Coverage Level

Very Low
Very High
Positive+

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
88.663Target Price
+48.42%Upside Space
Current Rating2026-082026-072026-062026-052026-042026-032026-022026-01
Strong Buy66877777
Buy1414141310101010
Hold65556666
Sell00000000
Strong Sell00000000

Ionis Pharmaceuticals Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Buy

Summary

Neutral

Moving Average

Neutral

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.69/-1.07
Revenue / Forecast
267.95M/190.67M

Ionis Pharmaceuticals Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolIONS
Number of employees1069
CountryUnited States of America

Ownership

ShareholdersProportion
Fidelity Management & Research Company LLC14.57%
Capital World Investors10.87%
T. Rowe Price Investment Management, Inc.5.51%
BlackRock Institutional Trust Company, N.A.5.22%
Shareholder TypesProportion
Investment Advisor70.17%
Investment Advisor/Hedge Fund19.99%
Hedge Fund12.11%
Research Firm1.99%

FAQs

What is the current price of Ionis Pharmaceuticals Inc (IONS)?

The current price of Ionis Pharmaceuticals Inc (IONS) is 59.74.

What is the symbol of Ionis Pharmaceuticals Inc?

The ticker symbol of Ionis Pharmaceuticals Inc is IONS.

What is the 52-week high of Ionis Pharmaceuticals Inc?

The 52-week high of Ionis Pharmaceuticals Inc is 86.74.

What is the 52-week low of Ionis Pharmaceuticals Inc?

The 52-week low of Ionis Pharmaceuticals Inc is 41.71.

What is the market capitalization of Ionis Pharmaceuticals Inc?

The market capitalization of Ionis Pharmaceuticals Inc is 9.90B.

Is Ionis Pharmaceuticals Inc (IONS) currently rated as Buy, Hold, or Sell?

According to analysts, Ionis Pharmaceuticals Inc (IONS) has an overall rating of Buy, with a price target of 88.66.

What is the Earnings Per Share (EPS TTM) of Ionis Pharmaceuticals Inc (IONS)?

The Earnings Per Share (EPS TTM) of Ionis Pharmaceuticals Inc (IONS) is -2.02.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.